Associate Director, Compliance – Field Commercialization
United States · Remote OK
$186k–$233k/yr
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Healthcare Compliance, Risk Mitigation, Stakeholder Management, Regulatory Guidance, Field Training
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Government Affairs Strategy, Market Access, Public Policy Analysis, HTA Planning, Pricing and Reimbursement
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Associate Director, Externally Sponsored Research Contracts
United States · Remote OK
$177k–$221k/yr
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Oncology Patient Access, Case Management, Hub Operations, People Management, Reimbursement Processes
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Country Management, Oncology Drug Launch, P&L Management, Market Access Strategy, Pricing Strategy
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Senior Director, Commercial Drug Product Manufacturing Operations
Redwood City, California, United States · Hybrid
$244k–$305k/yr
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Commercial Drug Product Manufacturing, CMO Management, Process Validation, PPQ Execution, Continued Process Verification
Senior Manager, Medical Science Liaison, Switzerland
Basel, Basel-City, Switzerland · Remote OK
Senior+
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: KOL Engagement, Scientific Communication, Medical Affairs, Oncology, Clinical Research
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Metabolite Identification, Structural Elucidation, High-Resolution Mass Spectrometry, Pharmacokinetic Data Analysis, WinNonlin
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical Operations, Study Management, GCP, ICH Guidelines, FDA Regulations
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Quality Validation, cGMP Compliance, Process Performance Qualification, Continued Process Verification, Cleaning Validation
Associate Director, Compliance – Field Commercialization
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
$186k–$233k/yr
Full-time
bachelor degree, postgraduate degree
Cash Compensation, Equity Awards, Learning And Development Opportunities
Posted 1d ago
~40 hrs/week
Remote in United States
Responsibilities
Lead the field-facing compliance strategy and program for Commercial and Medical organizations during product commercialization. This includes identifying compliance risks, developing scalable solutions, and overseeing training and monitoring activities.
Requirements
Requires a bachelor's degree and at least 12 years of experience in healthcare compliance, legal, or regulatory roles within the pharmaceutical industry. Proven ability to influence senior leadership and implement governance frameworks is essential.
Full job description
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
The Associate Director, Compliance – Field Commercialization, with support from the Sr. Director, Compliance, is responsible for leading the field-facing compliance strategy and program for Commercial and Medical field organizations during product commercialization and indication expansion. This role serves as a senior compliance business partner to Commercial and Medical business partners, providing strategic guidance that enables compliant execution while advancing organizational objectives.
Reporting to the Senior Director, Compliance, the Associate Director will lead the development, implementation, and continuous enhancement of a comprehensive field compliance program, embedding compliance into field operations and supporting the company's growth as a commercial-stage oncology organization. This role will proactively identify compliance risks, develop scalable solutions, and influence business decisions across a dynamic and evolving commercial environment.
Field Compliance Leadership
Serve as the lead compliance business partner for all Revolution Medicines field organizations, including Sales, Marketing, Medical Science Liaisons, and Reimbursement and Access teams.
Provide strategic compliance guidance to Commercial and Medical leadership regarding field execution, emerging risks, and business initiatives.
Lead the identification, assessment, and mitigation of compliance risks associated with field activities and commercialization efforts.
Develop and implement scalable compliance solutions that support evolving business needs, product launches, and indication expansions.
Partner closely with Legal, Compliance, Commercial, Medical, and Market Access leadership to ensure alignment of compliance strategy with business objectives.
Field Training & Communication
Own the strategy, design, and governance of field compliance training programs across Commercial and Medical organizations.
Develop risk-based training plans informed by monitoring insights, audit findings, industry trends, enforcement actions, and regulatory developments.
Serve as a senior presenter and facilitator for compliance training at national sales meetings, launch meetings, leadership forums, and onboarding programs.
Evaluate training effectiveness through metrics, feedback, and monitoring results and implement continuous improvements.
Policies, SOPs, and Governance
Lead the development, implementation, and governance of policies, SOPs, standards, and guidance impacting Commercial and Medical field activities.
Ensure compliance policies and procedures remain current with evolving regulatory requirements, industry standards, and business needs.
Drive cross-functional governance initiatives and facilitate alignment among Legal, Compliance, Commercial, and Medical stakeholders.
Establish practical frameworks, job aids, and guidance documents that enable consistent and compliant field execution.
Auditing, Monitoring & Risk Management
Lead compliance oversight of field-related auditing and monitoring activities in partnership with the Compliance Auditing and Monitoring function.
Analyze monitoring trends and audit results to identify systemic risks, root causes, and opportunities for process improvement.
Develop and oversee corrective and preventive action plans (CAPAs) related to field compliance observations.
Regularly communicate compliance risk assessments, trends, and recommendations to Compliance leadership and key business stakeholders.
Regulatory Knowledge & Industry Leadership
Maintain expert-level knowledge of healthcare laws, regulations, and industry guidance affecting Commercial and Medical field activities, including FDA, CMS, OIG, DOJ, HIPAA, state compliance requirements, data privacy laws, and the PhRMA Code.
Monitor industry trends, enforcement actions, and best practices to proactively assess potential impact on Revolution Medicines.
Represent Compliance on cross-functional governance committees, launch teams, and strategic business initiatives.
Contribute to the evolution of the company's compliance program through external benchmarking and industry engagement.
Product launch and indication expansion experience.
Experience leading compliance initiatives within a commercial-stage biotechnology company.
Strong project leadership and change management capabilities. #LI-Remote #LI-YG1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
Base Pay Salary Range
$186,000—$233,000 USD
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message. Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address. If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Revolution Medicine enables physicians to integrate personalized medicine into their practices in order to more effectively treat patients.
Our genes play an important role in determining how we respond to about 75% of prescription drugs. Scientific research has demonstrated which genes predict these responses. According to the American Medical Association (AMA), 98% of physicians agree that knowing a patient’s genetic profile would help in prescribing medications. Yet, 90% of physicians do not feel they are adequately informed about how to apply genetic testing to treatment decisions.
Our mission is to improve the quality of patient care by helping doctors determine optimal treatment strategies and more accurately predict treatment responses. Revolution Medicine has developed ScriptMatch, an analytical process that enables physicians to easily incorporate genetic testing into their practices.
Our company solves a major issue in the clinical market and addresses an emerging trend in patient-driven healthcare: having clinical results that become part of the medical record and applicable to future treatments.
Revolution Medicine enables physicians to integrate personalized medicine into their practices in order to more effectively treat patients.
Our genes play an important role in determining how we respond to about 75% of prescription drugs. Scientific research has demonstrated which genes predict these responses. According to the American Medical Association (AMA), 98% of physicians agree that knowing a patient’s genetic profile would help in prescribing medications. Yet, 90% of physicians do not feel they are adequately informed about how to apply genetic testing to treatment decisions.
Our mission is to improve the quality of patient care by helping doctors determine optimal treatment strategies and more accurately predict treatment responses. Revolution Medicine has developed ScriptMatch, an analytical process that enables physicians to easily incorporate genetic testing into their practices.
Our company solves a major issue in the clinical market and addresses an emerging trend in patient-driven healthcare: having clinical results that become part of the medical record and applicable to future treatments.